1. Home
  2. APRE vs MTEK Comparison

APRE vs MTEK Comparison

Compare APRE & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.89

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$1.38

Market Cap

12.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
MTEK
Founded
2006
2008
Country
United States
Israel
Employees
8
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
APRE
MTEK
Price
$0.89
$1.38
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
448.0K
156.3K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$1.03
52 Week High
$2.22
$4.27

Technical Indicators

Market Signals
Indicator
APRE
MTEK
Relative Strength Index (RSI) 55.78 49.19
Support Level $0.90 $1.08
Resistance Level $0.98 $1.50
Average True Range (ATR) 0.10 0.14
MACD 0.01 -0.00
Stochastic Oscillator 56.03 37.50

Price Performance

Historical Comparison
APRE
MTEK

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: